Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Enjyoji, J. Sévigny, Yuan Lin, P. Frenette, P. Christie, J. Esch, M. Imai, J. Edelberg, H. Rayburn, M. Lech, D. Beeler, E. Csizmadia, D. Wagner, S. Robson, R. Rosenberg (1999)
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulationNature Medicine, 5
C. Veer, Neal Golden, M. Kalafatis, K. Mann (1997)
Inhibitory Mechanism of the Protein C Pathway on Tissue Factor-induced Thrombin GenerationThe Journal of Biological Chemistry, 272
M. Sandrin, W. Fodor, S. Cohney, E. Mouhtouris, N. Osman, S. Rollins, S. Squinto, I. McKenzie (1996)
Reduction of the major porcine xenoantigen Galoc(1,3)Gal by expression of α(1,2)fucosyltransferaseXenotransplantation, 3
W. Fay, J. Murphy, W. Owen (1996)
High concentrations of active plasminogen activator inhibitor-1 in porcine coronary artery thrombi.Arteriosclerosis, thrombosis, and vascular biology, 16 10
Bijnens Bijnens, Knockaert Knockaert, Cousin Cousin, Kruithof Kruithof, Declerck Declerck (1997)
Expression and characterization of recom‐binant porcine plasminogen activator inhibitor‐1 (published erratum appears in Thromb Haemost 1997; 77: 1046)Thrombosis & Haemostasis, 77
L. Bajzar, M. Nesheim, J. Morser, P. Tracy (1998)
Both Cellular and Soluble Forms of Thrombomodulin Inhibit Fibrinolysis by Potentiating the Activation of Thrombin-activable Fibrinolysis Inhibitor*The Journal of Biological Chemistry, 273
A. Zaidi, M. Schmoeckel, F. Bhatti, P. Waterworth, M. Tolan, E. Cozzi, G. Chavez, G. Langford, S. Thiru, J. Wallwork, D. White, P. Friend (1998)
Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors.Transplantation, 65 12
M. Sandrin, W. Fodor, Effie Mouthtouris, N. Osman, S. Cohney, S. Rollins, E. Guilmette, E. Setter, S. Squinto, I. Mckenzie (1995)
Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysisNature Medicine, 1
E. Davis, F. Jakobs, S. Pruitt, P. Greene, Z. Qian, T. Lam, E. Tseng, J. Levin, W. Baldwin, F. Sanfilippo (1997)
Overcoming rejection in pig-to-primate cardiac xenotransplantation.Transplantation proceedings, 29 1-2
C. Li, L. Fung, S. Chung, A. Crow, N. Myers-Mason, M. Phillips, J. Leibowitz, E. Cole, C. Ottaway, G. Levy (1992)
Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infectionThe Journal of Experimental Medicine, 176
B. Lesnikoski, D. Candinas, I. Otsu, R. Metternich, F. Bach, S. Robson (1997)
Thrombin Inhibition in discordant xenograft rejectionXenotransplantation, 4
C. Kopp, Jonathan Siegel, W. Hancock, J. Anrather, H. Winkler, C. Geczy, E. Kaczmarek, F. Bach, S. Robson (1997)
Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors.Transplantation, 63 5
Shigeki Taniguchi, Surgeon, David Cooper (1997)
Clinical xenotransplantation: past, present and future.Annals of the Royal College of Surgeons of England, 79 1
A., P., Bijnens, I., Knockaert, E., Cousin, K. E., 0., Kruithof, Declerck (1997)
Expression and Characterization of Recombinant Porcine Plasminogen Activator Inhibitor-1Thrombosis and Haemostasis, 77
M. Imai, K. Takigami, O. Guckelberger, E. Kaczmarek, E. Csizmadia, F. Bach, S. Robson (2000)
RECOMBINANT ADENOVIRAL MEDIATED CD39 GENE TRANSFER PROLONGS CARDIAC XENOGRAFT SURVIVAL1Transplantation, 70
M. Francesconi, A. Casonato, Stefano Pagan, A. Donella‐Deana, E. Pontara, A. Girolami, R. Deana (1996)
Inhibitory Effect of Prostacyclin and Nitroprusside on Type IIB von Willebrand Factor-promoted Platelet ActivationThrombosis and Haemostasis, 76
C. Patience, Y. Takeuchi, R. Weiss (1997)
Infection of human cells by an endogenous retrovirus of pigsNature Medicine, 3
G. Gibbons, V. Dzau (1994)
The emerging concept of vascular remodeling.The New England journal of medicine, 330 20
S. Pruitt, R. Bollinger, B. Collins, H. Marsh, J. Levin, A. Rudolph, W. Baldwin, F. Sanfilippo (1997)
Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts.Transplantation, 63 6
U. Galili (1993)
Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans.Immunology today, 14 10
M. Dam-Mieras, A Muller, V. Hinsbergh, W. Mullers, P Bomans, C. Bruggeman (1992)
The Procoagulant Response of Cytomegalovirus Infected Endothelial CellsThrombosis and Haemostasis, 68
Daniel Candinas, B. Lesnikoski, Wayne Hancock, Ichiro Otsu, N. Koyamada, A. Dalmasso, Simon Robson, Fritz Bach (1996)
Inhibition of platelet integrin GPIIbIIIa prolongs survival of discordant cardiac xenografts.Transplantation, 62 1
Vantveer Vantveer, Golden Golden, Kalafatis Kalafatis, Mann Mann (1997)
Inhibitory mechanism of the protein c pathway on tissue factor‐induced thrombin generation – synergistic effect in combination with tissue factor pathway inhibitorJ Biol Chemistry, 272
Michaela Albertini, A. Palmetshofer, E. Kaczmarek, K. Koziak, D. Stroka, Shane T. Grey, K. Stuhlmeier, S. Robson (1998)
Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis.Biochemical and biophysical research communications, 248 3
A. Palmetshofer, U. Galili, A. Dalmasso, S. Robson, F. Bach (1998)
Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation.Transplantation, 65 7
(1997)
Genetic engineering of pigs for xenogeneic heart transplantation [French
Hoyu Takahashi, W. Tatewaki, Tadao Nakamura, M. Hanano, K. Wada, A. Shibata (1989)
Coagulation studies in thrombotic thrombocytopenic purpura, with special reference to von willebrand factor and protein SAmerican Journal of Hematology, 30
Miguel Soares, D. Latinne, Marc Elsen, J. Figueroa, Fritz Bach, H. Bazin (1993)
In vivo depletion of xenoreactive natural antibodies with an anti-mu monoclonal antibody.Transplantation, 56 6
K. McCurry, D. Kooyman, L. Diamond, G. Byrne, M. Martín, J. Logan, J. Platt (1995)
Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs.Transplantation proceedings, 27 1
E. Cozzi, A. Tucker, G. Langford, G. Pino-Chavez, L. Wright, M. O'connell, V. Young, R. Lancaster, M. McLaughlin, K. Hunt, M. Bordin, D. White (1997)
Characterization of pigs transgenic for human decay-accelerating factor.Transplantation, 64 10
Carolyn Wilson, Susan Wong, J. Muller, C. Davidson, T. Rose, P. Burd (1998)
Type C Retrovirus Released from Porcine Primary Peripheral Blood Mononuclear Cells Infects Human CellsJournal of Virology, 72
J. Frearson, D. Alexander (1996)
Protein tyrosine phosphatases in T-cell development, apoptosis and signalling.Immunology today, 17 8
T. Kawai, A. Cosimi, R. Colvin, J. Powelson, James Eason, Tomacsz Kozlowski, M. Sykes, R. Monroy, Mayumi Tanaka, D. Sachs (1995)
Mixed Allogeneic Chimerism And Renal Allograft Tolerance In Cynomolgus MonkeysTransplantation, 59
J. Platt, F. Bach (1991)
The barrier to xenotransplantation.Transplantation, 52 6
Soheyla Saadi, R. Holzknecht, Christian Patte, David Stern, andJeffrey Platt (1995)
Complement-mediated regulation of tissue factor activity in endotheliumThe Journal of Experimental Medicine, 182
D. Latinne, D. Vitiello, D. Sachs, M. Sykes (1994)
Tolerance to discordant xenografts. I. Sharing of human natural antibody determinants on miniature swine bone marrow cells and endothelial cells.Transplantation, 57 2
A. Coughlan, M. Berndt, L. Dunlop, W. Hancock (1993)
In vivo studies of P-selectin and platelet activating factor during endotoxemia, accelerated allograft rejection, and discordant xenograft rejection.Transplantation proceedings, 25 5
L. Makowka, F. Chapman, D. Cramer, S. Qian, Hong Sun, T. Starzl (1990)
PLATELET‐ACTIVATING FACTOR AND HYPERACUTE REJECTION: THE EFFECT OF A PLATELET‐ACTIVATING FACTOR ANTAGONIST, SRI 63–441, ON REJECTION OF XENOGRAFTS AND ALLOGRAFTS IN SENSITIZED HOSTSTransplantation, 50
M. Schmoeckel, G. Nollert, M. Shahmohammadi, J. Müller‐Höcker, Young Vk, W. Kasper-König, David White, Claus Hammer, B. Reichart (1996)
Transgenic human decay accelerating factor makes normal pigs function as a concordant species.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 16 7
A. Dalmasso (1992)
The complement system in xenotransplantation.Immunopharmacology, 24 2
F. Bach (1991)
Revisiting a challenge in transplantation: discordant xenografting.Human immunology, 30 4
S. Debrock, P. Declerck (1998)
Identification of a Functional Epitope in Plasminogen Activator Inhibitor-1, not Localized in the Reactive Center LoopThrombosis and Haemostasis, 79
A. Dalmasso, Gregory Vercellotti, R. Fischel, R. Bolman, F. Bach, Jeffrey Platt (1992)
Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients.The American journal of pathology, 140 5
D. O’Hair, A. Roza, R. Komorowski, G. Moore, R. McManus, C. Johnson, M. Adams, G. Pieper (1993)
Tulopafant, a PAF receptor antagonist, increases capillary patency and prolongs survival in discordant cardiac xenotransplants.Journal of lipid mediators, 7 1
F. Jakobs, E. Davis, T. White, F. Sanfilippo, W. Baldwin (1998)
Prolonged discordant xenograft survival by inhibition of the intrinsic coagulation pathway in complement C6-deficient recipients.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 17 3
Shane Grey, W. Hancock (1996)
A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes.Journal of immunology, 156 6
Robson Robson, Candinas Candinas, Hancock Hancock, Wrighton Wrighton, Winkler Winkler, Bach Bach (1995)
Role of endothelial cells in transplantation (Review)Int Arch Allergy Immunol, 106
Simon Robson, Daniel Candinas, Wayne Hancock, Christopher Wrighton, Hans Winkler, Fritz Bach (1995)
Role of endothelial cells in transplantation.International archives of allergy and immunology, 106 4
E. Kaczmarek, K. Koziak, J. Sévigny, Jonathan Siegel, J. Anrather, A. Beaudoin, F. Bach, S. Robson (1996)
Identification and Characterization of CD39/Vascular ATP Diphosphohydrolase*The Journal of Biological Chemistry, 271
A. Palmetshofer, U. Galili, A. Dalmasso, S. Robson, F. Bach (1998)
Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type I activation.Transplantation, 65 6
D. Candinas, N. Koyamada, Tsukasa Miyatake, J. Siegel, Wayne Hancock, Fritz Bach, S. Robson (1996)
Loss of Rat Glomerular ATP Diphosphohydrolase Activity during Reperfusion Injury Is Associated with Oxidative Stress ReactionsThrombosis and Haemostasis, 76
A. Tucker, C. Carrington, A. Richards, S. Robson, D. White (1997)
Endothelial cells from human decay acceleration factor transgenic pigs are protected against complement mediated tissue factor expression in vitro.Transplantation proceedings, 29 1-2
S. Saadi, Jeffrey Platt (1995)
Transient perturbation of endothelial integrity induced by natural antibodies and complementThe Journal of Experimental Medicine, 181
E. Pryzdial, J. Wright (1994)
Prothrombinase assembly on an enveloped virus: evidence that the cytomegalovirus surface contains procoagulant phospholipid.Blood, 84 11
C. Kopp, Shane T. Grey, Jonathan Siegel, A. Mcshea, H. Vetr, C. Wrighton, J. Esch, F. Bach, S. Robson (1998)
Expression of human thrombomodulin cofactor activity in porcine endothelial cells.Transplantation, 66 2
T. Starzl, R. Lerner, F. Dixon, C. Groth, L. Brettschneider, P. Terasaki (1968)
Shwartzman reaction after human renal homotransplantation.The New England journal of medicine, 278 12
M. Michaels (1997)
Infectious Concerns of Cross-Species Transplantation: XenozoonosesWorld Journal of Surgery, 21
M. Breimer, Staffan Björck, C. Svalander, A. Bengtsson, L. Rydberg, Kari Lie‐Karlsen, P. Attman, M. Aurell, B. Samuelsson (1996)
Extracorporeal (“ex vivo”) connection of pig kidneys to humans. I. Clinical data and studies of platelet destructionXenotransplantation, 3
L. Diamond, K. McCurry, Michael Martin, S. McClellan, Elizabeth Oldham, Jeffrey Platt, John Logan (1996)
Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium.Transplantation, 61 8
M. Schmoeckel, Farah Bhatti, A. Zaidi, E. Cozzi, P. Waterworth, M. Tolan, G. Pino-Chavez, Martin Goddard, R. Warner, G. Langford, John Dunning, J. Wallwork, David White (1998)
Orthotopic heart transplantation in a transgenic pig-to-primate model.Transplantation, 65 12
Jonathan Siegel, Shane T. Grey, B. Lesnikoski, Christoph Kopp, Miguel Soares, J. Esch, Fritz Bach, Simon Robson (1997)
Xenogeneic endothelial cells activate human prothrombin.Transplantation, 64 6
H. Gritsch, R. Glaser, D. Emery, Lorri Lee, Craig Smith, T. Sablinski, J. Arn, D. Sachs, M. Sykes (1994)
THE IMPORTANCE OF NONIMMUNE FACTORS IN RECONSTITUTION BY DISCORDANT XENOGENEIC HEMATOPOIETIC CELLS1,2Transplantation, 57
Jeffrey Platt (1996)
Xenotransplantation: recent progress and current perspectives.Current opinion in immunology, 8 5
D. Anrather, M. Millan, A. Palmetshofer, S. Robson, C. Geczy, A. Ritchie, F. Bach, B. Ewenstein (1997)
Thrombin activates nuclear factor-kappaB and potentiates endothelial cell activation by TNF.Journal of immunology, 159 11
M. Kalady, J. Lawson, Rachelle Sorrell, J. Platt (1998)
Decreased Fibrinolytic Activity in Porcine-to-Primate Cardiac XenotransplantationMolecular Medicine, 4
P. Cowan, A. Aminian, H. Barlow, A. Brown, Chao-Guang Chen, N. Fisicaro, D. Francis, D. Goodman, W. Han, M. Kurek, M. Nottle, M. Pearse, E. Salvaris, T. Shinkel, Gerard Stainsby, A. Stewart, A. D'apice (2000)
Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons.Transplantation, 69 12
S. Robson, E. Kaczmarek, J. Siegel, D. Candinas, K. Koziak, M. Millan, W. Hancock, F. Bach (1997)
Loss of ATP Diphosphohydrolase Activity with Endothelial Cell ActivationThe Journal of Experimental Medicine, 185
F. Bach, H. Winkler, C. Ferran, W. Hancock, S. Robson (1996)
Delayed xenograft rejection.World journal of surgery, 21 9
D. Altieri, O. Etingin, D. Fair, T. Brunck, J. Geltosky, D. Hajjar, T. Edgington (1991)
Structurally homologous ligand binding of integrin Mac-1 and viral glycoprotein C receptors.Science, 254 5035
S. Robson, J. Siegel, B. Lesnikoski, C. Kopp, D. Candinas, U. Ryan, F. Bach (1996)
Aggregation of human platelets induced by porcine endothelial cells is dependent upon both activation of complement and thrombin generationXenotransplantation, 3
Peerschke Peerschke, Reid Reid, Ghebrehiwet Ghebrehiwet (1993)
Platelet activation by C1q results in the induction of aII/bIII integrins and the expression of P‐selectin and procoagulant activityJ Exp Medicine, 178
Giulia Pucci, Massimo Martino, Fortunato Morabito, P. Iacopino, William Arcese, A. Iori, V. Lombardo, Amedeo L'Abbate, Marisa Santostefano, Francesco Nobile (1994)
Thrombotic thrombocytopenic purpura: a rare late complication of allogeneic bone marrow transplantation.Haematologica, 79 4
F. Bach, C. Ferran, M. Soares, C. Wrighton, J. Anrather, H. Winkler, S. Robson, W. Hancock (1997)
Modification of vascular responses in xenotransplantation: Inflammation and apoptosisNature Medicine, 3
B. Thorley, J. Milland, D. Christiansen, M. Lantéri, B. McInnes, I. Moeller, P. Rivailler, B. Horvat, C. Rabourdin-Combe, D. Gerlier, I. McKenzie, B. Loveland (1997)
Transgenic expression of a CD46 (membrane cofactor protein) minigene: Studies of xenotransplantation and measles virus infectionEuropean Journal of Immunology, 27
D. Akiyoshi, M. Denaro, Haihong Zhu, J. Greenstein, P. Banerjee, J. Fishman (1998)
Identification of a Full-Length cDNA for an Endogenous Retrovirus of Miniature SwineJournal of Virology, 72
L. Chapman, T. Folks, D. Salomon, Amy Patterson, T. Eggerman, P. Noguchi (1995)
Xenotransplantation and xenogeneic infections.The New England journal of medicine, 333 22
B. Wassmann, H. Martin, S. Elsner, J. Bruecher, F. Thaiss, R. Stahl, D. Hoelzer (1994)
Microangiopathic hemolytic anemia and renal impairment following autologous bone marrow transplantation: a case of hemolytic uremic syndrome?Bone marrow transplantation, 14 5
P. Toulon, M. Lamine, I. Ledjev, T. Guez, M. Holleman, D. Séréni, D. Sicard (1993)
Heparin Cofactor II Deficiency in Patients Infected with the Human Immunodeficiency VirusThrombosis and Haemostasis, 70
A. Rosengard, N. Cary, G. Langford, A. Tucker, J. Wallwork, D. White (1995)
TISSUE EXPRESSION OF HUMAN COMPLEMENT INHIBITOR, DECAY‐ACCELERATING FACTOR, IN TRANSGENIC PIGS A POTENTIAL APPROACH FOR PREVENTING XENOGRAFT REJECTIONTransplantation, 59
C. Veer, K. Mann (1997)
Regulation of Tissue Factor Initiated Thrombin Generation by the Stoichiometric Inhibitors Tissue Factor Pathway Inhibitor, Antithrombin-III, and Heparin Cofactor-II*The Journal of Biological Chemistry, 272
Jeffrey Lawson, Jeffrey Platt (1996)
Molecular barriers to xenotransplantation.Transplantation, 62 3
K. Kokame, Xinglong Zheng, J. Sadler (1998)
Activation of Thrombin-activable Fibrinolysis Inhibitor Requires Epidermal Growth Factor-like Domain 3 of Thrombomodulin and Is Inhibited Competitively by Protein C*The Journal of Biological Chemistry, 273
L. Bajzar, R. Manuel, M. Nesheim (1995)
Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor (*)The Journal of Biological Chemistry, 270
J. Hildebrand (1981)
A review of studies of the EORTC brain tumor group.Cancer treatment reports, 65 Suppl 2
D. Cooper, Y. Ye, M. Niekrasz, M. Kehoe, M. Martin, F. Neethling, S. Kosanke, L. Debault, G. Worsley, N. Zuhdi, R. Oriol, E. Romano (1993)
SPECIFIC INTRAVENOUS CARBOHYDRATE THERAPY A NEW CONCEPT IN INHIBITING ANTIBODY‐MEDIATED REJECTION—EXPERIENCE WITH ABO‐INCOMPATIBLE CARDIAC ALLOGRAFTING IN THE BABOONTransplantation, 56
M. Colvin, J. Hilton (1981)
Pharmacology of cyclophosphamide and metabolites.Cancer treatment reports, 65 Suppl 3
T. Kozłowski, Y. Fuchimoto, R. Monroy, M. Bailin, R. Martínez-Ruíz, A. Foley, Y. Xu, M. Awwad, J. Fishman, D. Andrews, J. Ritzenthaler, T. Sablinski, F. Ierino, D. Sachs (1997)
Apheresis and column absorption for specific removal of Gal-alpha-1,3 Gal natural antibodies in a pig-to-baboon model.Transplantation proceedings, 29 1-2
M. Furlan, R. Robles, M. Solenthaler, Max Wassmer, P. Sandoz, B. Lämmle (1997)
Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.Blood, 89 9
J. Platt, F. Bach (1991)
Discordant xenografting: challenges and controversies.Current opinion in immunology, 3 5
Jeffrey Platt (1996)
The immunological barriers to xenotransplantation.Critical reviews in immunology, 16 4
H. Hayashi, R. Lee, S. Germana, C. Fraser, M. Sykes, D. Sachs, C. Leguern (1995)
Retroviral vectors for long-term expression of allogeneic major histocompatibility complex transduced into syngeneic bone marrow cells.Transplantation proceedings, 27 1
J. Rosenberg, R. Broersma, G. Bullemer, E. Mammen, R. Lenaghan, B. Rosenberg (1969)
RELATIONSHIP OF PLATELETS, BLOOD COAGULATION, AND FIBRINOLYSIS TO HYPERACUTE REJECTION OF RENAL XENOGRAFTSTransplantation, 8
S. Robson, V. Young, N. Cook, G. Kottirsch, J. Siegel, B. Lesnikoski, D. Candinas, D. White, F. Bach (1996)
Inhibition of platelet GPIIbIa in an ex vivo model of hyperacute xenograft rejection does not prolong cardiac survival timeXenotransplantation, 3
K. McCurry, D. Kooyman, C. Alvarado, A. Cotterell, Michael Martin, J. Logan, J. Platt (1995)
Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injuryNature Medicine, 1
S. Lin, B. Weidner, G. Byrne, L. Diamond, J. Lawson, C. Hoopes, L. Daniels, C. Daggett, W. Parker, R. Harland, R. Davis, R. Bollinger, J. Logan, J. Platt (1998)
The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants.The Journal of clinical investigation, 101 8
S. Robson, J. Esch, F. Bach (1999)
Factors in Xenograft RejectionAnnals of the New York Academy of Sciences, 875
Imai Imai, Takigama Takigama, Guckelberger Guckelberger (1999)
Modu‐lation of nucleoside triphosphate diphosphohydrolase‐1/CD39 in xenograft rejectionMol Med, 5
J. Esch, Miguel Cruz, Jonathan Siegel, Josef Anrather, S. Robson (1997)
Activation of human platelets by the membrane-expressed A1 domain of von Willebrand factor.Blood, 90 11
L. Bühler, M. Basker, I. Alwayn, C. Goepfert, H. Kitamura, T. Kawai, S. Gojo, T. Kozłowski, F. Ierino, M. Awwad, D. Sachs, R. Sackstein, S. Robson, D. Cooper (2000)
COAGULATION AND THROMBOTIC DISORDERS ASSOCIATED WITH PIG ORGAN AND HEMATOPOIETIC CELL TRANSPLANTATION IN NONHUMAN PRIMATESTransplantation, 70
S. Robson, V. Young, N. Cook, R. Metternich, W. Kasper-Konig, B. Lesnikoski, R. Pierson, W. Hancock, D. Candinas, D. White, F. Bach (1996)
Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection.Transplantation, 61 6
N. Koyamada, Tsukasa Miyatake, Daniel Candinas, P. Hechenleitner, Jonathan Siegel, Wayne Hancock, Fritz Bach, Simon Robson (1996)
Apyrase administration prolongs discordant xenograft survival.Transplantation, 62 12
W. Parker, S. Saadi, Shu-sen Lin, Z. Holzknecht, M. Bustos, J. Platt (1996)
Transplantation of discordant xenografts: a challenge revisited.Immunology today, 17 8
R. Broersma, G. Bullemer, J. Rosenberg, R. Lenaghan, B. Rosenberg, E. Mammen (1969)
Coagulation changes in hyperacute rejection of renal xenografts.Thrombosis et diathesis haemorrhagica. Supplementum, 36
M. Imai, K. Takigami, O. Guckelberger, K. Enjyoji, Rex Smith, Yuan Lin, E. Csizmadia, J. Sévigny, R. Rosenberg, F. Bach, S. Robson (1999)
Modulation of Nucleotide Triphosphate Diphosphohydrolase-1 (NTPDase-1)/cd39 in Xenograft RejectionMolecular Medicine, 5
C. Kopp, S. Robson, J. Siegel, J. Anrather, H. Winkler, S. Grey, E. Kaczmarek, F. Bach, C. Geczy (1998)
Regulation of Monocyte Tissue Factor Activity by Allogeneic and Xenogeneic Endothelial CellsThrombosis and Haemostasis, 79
Tomasz Kozlowski, A. Shimizu, D. Lambrigts, Kazuhiko Yamada, Yasushi Fuchimoto, Roseann Glaser, Rod Monroy, Yuanxin Xu, M. Awwad, Robert Colvin, A. Cosimi, Simon Robson, Jay Fishman, Thomas Spitzer, D. Cooper, David Sachs (1999)
Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption.Transplantation, 67 1
B. Collins, R. Chari, J. Magee, R. Harland, B. Lindman, J. Logan, R. Bollinger, W. Meyers, J. Platt (1995)
Immunopathology of porcine livers perfused with blood of humans with fulminant hepatic failure.Transplantation proceedings, 27 1
J. Platt (1998)
New directions for organ transplantation.Nature, 392 6679 Suppl
R. Oriol, Y. Ye, E. Koren, D. Cooper (1993)
CARBOHYDRATE ANTIGENS OF PIG TISSUES REACTING WITH HUMAN NATURAL ANTIBODIES AS POTENTIAL TARGETS FOR HYPERACUTE VASCULAR REJECTION IN PIG‐TO‐MAN ORGAN XENOTRANSPLANTATION1Transplantation, 56
Carole Meyer, Philippe Wolf, Nathalie Romain, C. Ravanat, Jacqueline Roussi, Jean-Paul Beller, Pierre Imbs, Marie-Pierre Chenard, Michel Fabre, René Kieny, Michel Bonneau, Ludovic Drouet, J.-P. Cazenave, J. Soulillou, A. Azimzadeh (1999)
Use of von Willebrand diseased kidney as donor in a pig-to-primate model of xenotransplantation.Transplantation, 67 1
J. Platt, Shu-sen Lin, C. McGregor (1998)
Acute vascular rejectionXenotransplantation, 5
T. Starzl, H. Boehmig, H. Amemiya, C. Wilson, F. Dixon, G. Giles, K. Simpson, C. Halgrimson (1970)
Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection.The New England journal of medicine, 283 8
Kozlowski Kozlowski, Fuchimoto Fuchimoto, Monroy Monroy (1997)
1, 3 Gal natural antibodies in a pig–to–baboon modelTransplant Proc, 29
Ian Alwayn, L. Buhler, J. Appel, C. Goepfert, E. Csizmadia, L. Correa, D. Harper, H. Kitamura, J. Down, M. Awwad, R. Sackstein, D. Cooper, S. Robson (2001)
MECHANISMS OF THROMBOTIC MICROANGIOPATHY FOLLOWING XENOGENEIC HEMATOPOIETIC PROGENITOR CELL TRANSPLANTATION1Transplantation, 71
(1998)
using genetically modi ® ed donors
Robson Robson, Schulte Am Esch Schulte Am Esch, Bach Bach (1999)
Factors in xenograft rejectionAnn NY Acad Sci, 875
F. Pareti, M. Mazzucato, E. And, P. Mannucci (1992)
Interaction of porcine von Willebrand factor with the platelet glycoproteins Ib and IIb/IIIa complexBritish Journal of Haematology, 82
F. Bach, S. Robson, C. Ferran, H. Winkler, M. Millan, K. Stuhlmeier, B. Vanhove, Martin Blabcely, W. Werf, E. Hofer, R. Martin, W. Hancock (1994)
Endothelial Cell Activation and Thromboregulation during Xenograft RejectionImmunological Reviews, 141
A. Palmetshofer, S. Robson, F. Bach (1998)
Tyrosine phosphorylation following lectin meiated endothelial cell stimulationXenotransplantation, 5
J. Platt, G. Vercellotti, Bonnie Lindman, T. Oegema, F. Bach, A. Dalmasso (1990)
Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejectionThe Journal of Experimental Medicine, 171
M. Mazzucato, L. Marco, P. Pradella, A. Masotti, F. Pareti (1996)
Porcine von Willebrand Factor Binding to Human Platelet GPIb Induces Transmembrane Calcium InfluxThrombosis and Haemostasis, 75
G. Byrne, K. McCurry, K. McCurry, Michael Martin, S. McClellan, J. Platt, J. Logan (1997)
Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage.Transplantation, 63 1
A. Dorling, Robert Lechler (1994)
Prospects for xenografting.Current opinion in immunology, 6 5
F. Ierino, T. Kozłowski, Jonathan Siegel, A. Shimizu, R. Colvin, P. Banerjee, D. Cooper, Cosimi Ab, F. Bach, D. Sachs, S. Robson (1998)
Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts.Transplantation, 66 11
A. Amirkhosravi, M. Alexander, K. May, Debby Francis, Gary Warnes, J. Biggerstaff, John Francis (1996)
The Importance of Platelets in the Expression of Monocyte Tissue Factor Antigen Measured by a New Whole Blood Flow Cytometric AssayThrombosis and Haemostasis, 75
L. Bühler, C. Goepfert, H. Kitamura, M. Basker, S. Gojo, I. Alwayn, Q. Chang, J. Down, H. Tsai, R. Wise, D. Sachs, D. Cooper, S. Robson, R. Sackstein (2001)
Porcine hematopoietic cell xenotransplantation in nonhuman primates is complicated by thrombotic microangiopathyBone Marrow Transplantation, 27
K. Jurd, R. Gibbs, B. Hunt (1996)
Activation of human prothrombin by porcine aortic endothelial cells—a potential barrier to pig to human xenotransplantationBlood Coagulation & Fibrinolysis, 7
M. Sutherland, C. Raynor, H. Leenknegt, J. Wright, E. Pryzdial (1997)
Coagulation initiated on herpesviruses.Proceedings of the National Academy of Sciences of the United States of America, 94 25
D. Candinas, B. Lesnikoski, S. Robson, T. Miyatake, S. Scesney, H. Marsh, U. Ryan, A. Dalmasso, W. Hancock, F. Bach (1996)
Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival.Transplantation, 62 3
B. van, Veer, T. Hackeng, Cécile Delahaye, J. Sixma, B. Bouma (1994)
Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.Blood, 84 4
H. Wada, T. Kaneko, M. Ohiwa, M. Tanigawa, Tatsuya Hayashi, S. Tamaki, N. Minami, K. Deguchi, Koji Suzuki, Takeshi Nakano, S. Shirakawa (1993)
Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpuraAmerican Journal of Hematology, 44
Gibbons Gibbons, Dzau Dzau (1994)
The emerging concept of vascular remodeling (Review)New England J Med, 330
R. Sarode, J. Mcfarland, N. Flomenberg, J. Casper, E. Cohen, W. Drobyski, R. Ash, M. Horowitz, B. Camitta, C. Lawton, F. Garbrecht, J. Gottschall (1995)
Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation.Bone marrow transplantation, 16 2
O. Etingin, R. Silverstein, D. Hajjar (1993)
von Willebrand factor mediates platelet adhesion to virally infected endothelial cells.Proceedings of the National Academy of Sciences of the United States of America, 90 11
Elizabeth Davis, Scott Pruitt, Peter Greene, Sherif Ibrahim, Tuan Lam, James Levin, William Baldwin, Fred Sanfilippo (1996)
Inhibition of complement, evoked antibody, and cellular response prevents rejection of pig-to-primate cardiac xenografts.Transplantation, 62 7
Russell Other, W. Fodor, J. Springhorn, C. Birks, E. Setter, M. Sandrin, S. Squinto, S. Rollins (1995)
A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibodyThe Journal of Experimental Medicine, 182
O. Etingin, R. Silverstein, D. Hajjar (1991)
Identification of a monocyte receptor on herpesvirus-infected endothelial cells.Proceedings of the National Academy of Sciences of the United States of America, 88
G. Mazure, J. Grundy, G. Nygård, M. Hudson, K. Khan, K. Srai, A. Dhillon, R. Pounder, A. Wakefield (1994)
Measles virus induction of human endothelial cell tissue factor procoagulant activity in vitro.The Journal of general virology, 75 ( Pt 11)
Jeffrey Lawson, L. Daniels, J. Platt (1997)
The evaluation of thrombomodulin activity in porcine to human xenotransplantation.Transplantation proceedings, 29 1-2
E. Peerschke, K. Reid, B. Ghebrehiwet (1993)
Platelet activation by C1q results in the induction of alpha IIb/beta 3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activityThe Journal of Experimental Medicine, 178
A. Dalmasso, J.L PIatt, F. Bach (1991)
REACTION OF COMPLEMENT WITH ENDOTHEUAL CELLS IN A MODEL OF XEN0TRANSPLANTATIONClinical & Experimental Immunology, 86
Abstract: Rejection of xenografts is associated with vascular‐based inflammation, thrombocytopenia and the consumption of coagulation factors that may evolve into disseminated intravascular coagulation (DIC). Similarly, bone marrow‐derived cellular xenotransplantation procedures are associated with endothelial cell activation and thrombotic microangiopathic injury. These complications generally develop despite the best available measures for depletion of xenoreactive natural antibody, inhibition of complement activation and suppression of T‐ and B‐cell mediated immune responses. The mechanisms underlying the DIC and thrombotic microangiopathy associated with xenotransplantation are unclear. A proposed primary biological dysfunction of xenografts with respect to regulation of clotting could amplify vascular injury, promote immunological responses and independently contribute to graft failure. Disordered thromboregulation could have deleterious effects, comparable to unregulated complement activation, in the pathogenesis of xenograft rejection and may therefore represent a substantive barrier to xenotransplantation.
Xenotransplantation – Wiley
Published: Aug 1, 2000
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.